Clinical trial

Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies

NCT01292460

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-02-01

PhasePHASE3

Study timeline

Study start (unknown)2011-02-01Date precision: month

Registry last updated2013-03-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Ocular Hypertensionunresolved

Open-angle Glaucomaunresolved

Interventions

Timolol/ FDC/ Placebo/ TafluprostDRUG

Sponsors & collaborators

Santen Oylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01292460 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.